BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 19287466)

  • 21. Extensive genetic alterations of the HLA region, including homozygous deletions of HLA class II genes in B-cell lymphomas arising in immune-privileged sites.
    Riemersma SA; Jordanova ES; Schop RF; Philippo K; Looijenga LH; Schuuring E; Kluin PM
    Blood; 2000 Nov; 96(10):3569-77. PubMed ID: 11071656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Primary central nervous system diffuse large B cell lymphoma: a clinicopathologic and molecular study].
    Ma ZP; Ainiwaer B; Liu ZY; Shi XL; Cui WL; Zhang W; Li XX
    Zhonghua Bing Li Xue Za Zhi; 2016 Nov; 45(11):762-768. PubMed ID: 27821230
    [No Abstract]   [Full Text] [Related]  

  • 23. Aberrant ERG expression associates with downregulation of miR-4638-5p and selected genomic alterations in a subset of diffuse large B-cell lymphoma.
    Zhang S; Wang L; Cheng L
    Mol Carcinog; 2019 Oct; 58(10):1846-1854. PubMed ID: 31237044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thyroid carcinoma-associated genetic mutations also occur in thyroid lymphomas.
    Aggarwal N; Swerdlow SH; Kelly LM; Ogilvie JB; Nikiforova MN; Sathanoori M; Nikiforov YE
    Mod Pathol; 2012 Sep; 25(9):1203-11. PubMed ID: 22575864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epstein-Barr Virus Infection of Cell Lines Derived from Diffuse Large B-Cell Lymphomas Alters MicroRNA Loading of the Ago2 Complex.
    Ayoubian H; Ludwig N; Fehlmann T; Menegatti J; Gröger L; Anastasiadou E; Trivedi P; Keller A; Meese E; Grässer FA
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30429351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system.
    Baraniskin A; Kuhnhenn J; Schlegel U; Chan A; Deckert M; Gold R; Maghnouj A; Zöllner H; Reinacher-Schick A; Schmiegel W; Hahn SA; Schroers R
    Blood; 2011 Mar; 117(11):3140-6. PubMed ID: 21200023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum miR-22 as potential non-invasive predictor of poor clinical outcome in newly diagnosed, uniformly treated patients with diffuse large B-cell lymphoma: an explorative pilot study.
    Marchesi F; Regazzo G; Palombi F; Terrenato I; Sacconi A; Spagnuolo M; Donzelli S; Marino M; Ercolani C; Di Benedetto A; Blandino G; Ciliberto G; Mengarelli A; Rizzo MG
    J Exp Clin Cancer Res; 2018 May; 37(1):95. PubMed ID: 29716630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Presence of simian virus 40 in diffuse large B-cell lymphomas in Tunisia correlates with germinal center B-cell immunophenotype, t(14;18) translocation, and P53 accumulation.
    Amara K; Trimeche M; Ziadi S; Laatiri A; Mestiri S; Sriha B; Mokni M; Korbi S
    Mod Pathol; 2008 Mar; 21(3):282-96. PubMed ID: 18165800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AIDS and non-AIDS diffuse large B-cell lymphomas express different antigen profiles.
    Madan R; Gormley R; Dulau A; Xu D; Walsh D; Ramesh KH; Cannizaro L; Tamas EF; Kumar P; Sparano J; LeValley A; Xue X; Bhattacharyya PK; Ioachim HL; Ratech H
    Mod Pathol; 2006 Mar; 19(3):438-46. PubMed ID: 16444194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Expression of microRNA-223 and its clinicopathologic correlation in diffuse large B-cell lymphoma].
    Yao XX; Wang JF; Wang YH; Gao N
    Zhonghua Bing Li Xue Za Zhi; 2012 Jun; 41(6):366-70. PubMed ID: 22932402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diffuse large B-cell lymphoma involving the central nervous system.
    Gualco G; Weiss LM; Barber GN; Bacchi CE
    Int J Surg Pathol; 2011 Feb; 19(1):44-50. PubMed ID: 21087986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activated B-cell immunophenotype might be associated with poor prognosis of primary central nervous system lymphomas.
    Bhagavathi S; Sharathkumar A; Hunter S; Sung L; Kanhere R; Venturina MD; Wilson JD
    Clin Neuropathol; 2008; 27(1):13-20. PubMed ID: 18257470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary testicular diffuse large B-cell lymphoma shows an activated B-cell-like phenotype.
    Li D; Xie P; Mi C
    Pathol Res Pract; 2010 Sep; 206(9):611-5. PubMed ID: 20627604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targetable genetic features of primary testicular and primary central nervous system lymphomas.
    Chapuy B; Roemer MG; Stewart C; Tan Y; Abo RP; Zhang L; Dunford AJ; Meredith DM; Thorner AR; Jordanova ES; Liu G; Feuerhake F; Ducar MD; Illerhaus G; Gusenleitner D; Linden EA; Sun HH; Homer H; Aono M; Pinkus GS; Ligon AH; Ligon KL; Ferry JA; Freeman GJ; van Hummelen P; Golub TR; Getz G; Rodig SJ; de Jong D; Monti S; Shipp MA
    Blood; 2016 Feb; 127(7):869-81. PubMed ID: 26702065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clonal Evolution in Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System.
    Garcia-Reyero J; Martinez Magunacelaya N; Gonzalez Pereña A; Marcos Gonzalez S; Teran-Villagra N; Azueta A; Batlle A; Gonzalez de Villambrosia S; Revert Arce J; Montes-Moreno S
    Appl Immunohistochem Mol Morphol; 2020 Sep; 28(8):e68-e71. PubMed ID: 29629945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activity and complexes of mTOR in diffuse large B-cell lymphomas--a tissue microarray study.
    Sebestyén A; Sticz TB; Márk A; Hajdu M; Timár B; Nemes K; Nagy N; Váradi Z; Kopper L
    Mod Pathol; 2012 Dec; 25(12):1623-8. PubMed ID: 22899290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening and identification of differentially expressed microRNAs in diffuse large B-cell lymphoma based on microRNA microarray.
    Gao HX; Li SJ; Wang MB; Yan SF; Cui WL; Ma ZP; Xue J; Sang W; Zhang W; Li XX
    Oncol Lett; 2021 Nov; 22(5):753. PubMed ID: 34539857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of ataxia-telangiectasia mutated protein expression in diffuse large B-cell lymphomas of primary central nervous system and non-central nervous system origin.
    Kim SH; Cheong JW; Park KH; Kim TS; Yang WI
    Arch Pathol Lab Med; 2007 Mar; 131(3):457-67. PubMed ID: 17516749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma.
    Landsburg DJ; Petrich AM; Abramson JS; Sohani AR; Press O; Cassaday R; Chavez JC; Song K; Zelenetz AD; Gandhi M; Shah N; Fenske TS; Jaso J; Medeiros LJ; Yang DT; Nabhan C
    Cancer; 2016 Feb; 122(4):559-64. PubMed ID: 26565895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A microRNA signature profile in EBV+ diffuse large B-cell lymphoma of the elderly.
    Andrade TA; Evangelista AF; Campos AH; Poles WA; Borges NM; Camillo CM; Soares FA; Vassallo J; Paes RP; Zerbini MC; Scapulatempo C; Alves AC; Young KH; Colleoni GW
    Oncotarget; 2014 Dec; 5(23):11813-26. PubMed ID: 25544772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.